New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study

References

Page 1

	Year	Citations
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) The Lancet Metabolic SyndromeDiabetes ManagementInsulin ManagementDiabetesType 2	1998	19.9K
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care Expert CommitteeDiabetes ManagementDiabetesClinical EpidemiologyDiagnosis	2002	10.4K
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. R. C. Turner, Charles Fox, Matthews, The Lancet Metabolic SyndromeDiabetes ManagementDiabetes EpidemiologyInsulin ManagementDiabetes	1998	8.4K
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 UK Prospective Diabetes Study Group BMJ	1998	6.7K
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care Expert CommitteeDiabetes ManagementDiabetesClinical EpidemiologyDiagnosis	1997	6.2K
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 M R Stearne, S L Palmer, M S Hammersley,	1998	4.8K
Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial Jeremiah Stamler, Olga Vaccaro, James D. Neaton, Diabetes Care	1993	4.1K
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association Austen Wg, Je. Edwards, RL Frye, Circulation Ad Hoc CommitteeReporting SystemHealth PolicyCardiovascular DiseaseCoronary Artery Disease	1975	3.2K
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. James H. Chesebro, Genell L. Knatterud, Robert Roberts, Circulation ThrombosisHospital DischargeCardiovascular DiseaseIntravenous StreptokinaseAtherosclerosis	1987	2.2K
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. Robert D. Turner, R Holman HypertensionBlood PressureMetabolic SyndromeDiabetes EpidemiologyUkpds 38	1998	2K

Page 1